Discovery of olmesartan hexetil: A new potential prodrug of olmesartan

Synthesis of a new ester prodrug of olmesartan, olmesartan hexetil (1), is described. It is in vitro stabilities and in vivo pharmacokinetics (PK) were evaluated. It showed high stability in simulated gastric juice, and was rapidly hydrolyzed to olmesartan in rat liver microsomes and rat plasma in v...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters Vol. 23; no. 5; pp. 1347 - 1350
Main Authors: El-Gamal, Mohammed I., Anbar, Hanan S., Chung, Hye Jin, Kim, Hyun-Il, Cho, Young-Jin, Lee, Bong Sang, Lee, Sun Ahe, Moon, Ji Yun, Lee, Dong Jin, Kwon, Dow, Choi, Won-Jai, Jeon, Hong-Ryeol, Oh, Chang-Hyun
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-03-2013
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Synthesis of a new ester prodrug of olmesartan, olmesartan hexetil (1), is described. It is in vitro stabilities and in vivo pharmacokinetics (PK) were evaluated. It showed high stability in simulated gastric juice, and was rapidly hydrolyzed to olmesartan in rat liver microsomes and rat plasma in vitro. Cmax and AUClast for olmesartan were significantly increased in case of hexetil prodrug, compared with olmesartan medoxomil. Olmesartan hexetil is proposed to be an efficient prodrug of olmesartan with markedly increased oral bioavailability.
Bibliography:http://dx.doi.org/10.1016/j.bmcl.2012.12.090
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2012.12.090